Topic: Peptides

The "Wolverine" peptide stack has gained popularity for muscle growth, but medical experts warn of severe risks including pancreatitis and potential melanoma. Many peptides sold online from Chinese sources lack human safety trials and vary wildly in purity (50% to 300%), leading to accidental overdoses. Pharmaceutical companies like Eli Lilly are now moving to regulate these substances as they gain mainstream attention.

A discussion on peptides and GLP-1 weight loss drugs explores a University of Colorado study suggesting these drugs may reduce brain inflammation and improve attention. The hosts joke that taking GLP-1s might lead people to vote Democrat. They plan a "deep dive" into the peptide subculture for a future show, noting the high number of "peptide nuts" among their audience.

Eli Lilly is developing a new obesity medication called Retatrutide, which targets three different hormones (GLP-1, GIP, and glucagon). Clinical trials show patients lost an average of 70 pounds over 80 weeks, significantly outperforming placebos. The hosts discuss whether this is simply a repackaged peptide that is already available through "peptide dealers."

A hot mic captured Xi Jinping and Vladimir Putin discussing biotechnology and organ transplants during a military parade in Beijing. While some outlets linked the conversation to allegations of state-sanctioned organ harvesting from Falun Gong practitioners, a deconstruction suggests the leaders were discussing life extension and mortality. Putin's interest in peptides and anti-aging treatments is also noted.

A recent birthday celebration for the heiress of the Burger King franchise took place at the Bully Winery tasting room in Texas. The event marked her 70th birthday, prompting a discussion about the aesthetics of aging and the use of peptides to maintain health. The hosts reflect on the history of the Burger King brand and its commercialization by the heiress's father.

Joe S. Chinaman, newly knighted as Sir Olympus, announced the launch of his biotech startup, PetriBio. The company focuses on developing treatments for aging-related diseases by utilizing peptides and biomolecules from the gut microbiome. He requested "PCR primers and master mix" for the No Agenda roundtable.